-
大分大学をはじめとするアカデミア発共同開発シーズのライセンス機関として、知財特許の確保と開発戦略をたて、創薬につなげます。
IAM serves as a licensing agent for seminal technologies developed through partnerships with academia, notably including Oita University. IAM secures patents and other intellectual property and proposes effective development strategies leading to drug development.
-
技術移転事業Technology transfer